Your browser doesn't support javascript.
COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms.
Giannetti, Matthew P; Weller, Emily; Alvarez-Twose, Iván; Torrado, Inés; Bonadonna, Patrizia; Zanotti, Roberta; Dwyer, Daniel F; Foer, Dinah; Akin, Cem; Hartmann, Karin; Rama, Tiago Azenha; Sperr, Wolfgang R; Valent, Peter; Teodosio, Cristina; Orfao, Alberto; Castells, Mariana.
  • Giannetti MP; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.
  • Weller E; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass.
  • Alvarez-Twose I; Instituto de Estudios de Mastocitosis de Castilla-La Mancha (CLMast)-Spanish Reference Center for Mastocytosis, Hospital Virgen del Valle, Complejo Hospitalario de Toledo, Toledo, Spain.
  • Torrado I; Instituto de Estudios de Mastocitosis de Castilla-La Mancha (CLMast)-Spanish Reference Center for Mastocytosis, Hospital Virgen del Valle, Complejo Hospitalario de Toledo, Toledo, Spain.
  • Bonadonna P; Allergy Unit, Verona University Hospital, Verona, Italy.
  • Zanotti R; Department of Medicine, Section of Hematology, Verona, Italy.
  • Dwyer DF; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.
  • Foer D; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.
  • Akin C; Division of Allergy and Immunology, University of Michigan, Ann Arbor, Mich.
  • Hartmann K; Division of Allergy, University Hospital Basel and University Basel, Basel, Switzerland.
  • Rama TA; Serviço de Imunoalergologia, Centro Hospitalar Universitário de São João, Porto, Portugal; Serviço de Imunologia Básica e Clínica, Departamento de Patologia, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.
  • Sperr WR; Department of Internal Medicine I, Division of Hematology and Hemostaseology and Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Valent P; Department of Internal Medicine I, Division of Hematology and Hemostaseology and Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Teodosio C; Department of Immunology, Leiden Medical Center, Leiden, the Netherlands.
  • Orfao A; Cancer Translational Research Program, Cancer Research Center (IBMCC-CSIC/USAL), Department of Medicine, Sequencing Service and Cytometry Service (NUCLEUS), University of Salamanca (USAL), Biomedical Research Institute of Salamanca (IBSAL) and CIBERONC (Salamanca, Spain).
  • Castells M; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass. Electronic address: mcastells@bwh.harvard.edu.
J Allergy Clin Immunol Pract ; 9(5): 2083-2086, 2021 05.
Article in English | MEDLINE | ID: covidwho-1096027

Full text: Available Collection: International databases Database: MEDLINE Main subject: Mastocytosis / COVID-19 Type of study: Diagnostic study / Experimental Studies Limits: Humans Language: English Journal: J Allergy Clin Immunol Pract Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Mastocytosis / COVID-19 Type of study: Diagnostic study / Experimental Studies Limits: Humans Language: English Journal: J Allergy Clin Immunol Pract Year: 2021 Document Type: Article